DNA double-strand breaks (DSBs) are toxic DNA lesions which, if not properly repaired, may lead to genomic instability, cell death and senescence. Damage-induced long non-coding RNAs (dilncRNAs) are transcribed from broken DNA ends and contribute to DNA damage response (DDR) signaling. Here we show that dilncRNAs play a role in DSB repair by homologous recombination (HR) by contributing to the recruitment of the HR proteins BRCA1, BRCA2, and RAD51, without affecting DNA-end resection. In S/G2-phase cells, dilncRNAs pair to the resected DNA ends and form DNA:RNA hybrids, which are recognized by BRCA1 and promote its recruitment to DSBs. We also show that RNase H2 is in a complex with the HR proteins BRCA1, PALB2, BRCA2, and RAD51, and that it localizes to DSBs in the S/G2 cell-cycle phase. BRCA2 controls DNA:RNA hybrid levels at DSBs by mediating RNase H2 recruitment and, therefore, hybrids degradation. These results demonstrate that regulated DNA:RNA hybrid levels at DSBs contribute to HR-mediated repair.
Introduction
DNA double-strand breaks (DSBs) are some of the most toxic DNA lesions, since their inaccurate repair may result in mutations that contribute to cancer onset and progression, and to the development of neurological and immunological disorders 1 by re-ligation of the broken DNA ends in a process known as non-homologous end-joining (NHEJ) 5 . However, during the S/G2 cell-cycle phase, DSBs undergo resection, which directs repair toward homology-based mechanisms 6 . DNA-end resection is a process initiated by the coordinated action of the MRE11 nuclease within the MRN complex, together with C-terminal binding protein (CtBP) interacting protein (CtIP), and continued by exonuclease 1 (EXO1) 7 . Resected DNA ends are coated by RPA, which contributes to DDR signaling and undergoes a DNA damage-dependent hyper-phosphorylation 8 . When complementary sequences are exposed upon resection of both the DSB ends, RAD52 mediates their annealing via a process called single-strand annealing (SSA) resulting in the loss of genetic information 6 . Alternatively, a homologous sequence located on the sister chromatid or on the homologous chromosome can be used as a template for repair in a process known as homologous recombination (HR) 9 . The invasion of the homologous sequence is mediated by the recombinase RAD51, whose loading on the ssDNA ends is promoted by breast cancer 2 (BRCA2), which binds BRCA1 through the partner and localizer of BRCA2 (PALB2) 10, 11 . BRCA1, together with its constitutive heterodimer BARD1, is a multifaceted protein with several roles in DDR signaling and repair 12 . BRCA1 and BRCA2 genes are the most frequently mutated genes in breast and ovarian cancer 13 and recently-developed drugs, such as poly(ADPribose) polymerases (PARP) inhibitors, selectively target cancer cells harboring mutations in these genes 14 . Among its several functions, BRCA1 promotes DNA-end resection, mainly by counteracting the inhibitory effect of 53BP1 15 . Indeed, the HR defect in BRCA1-deficient cells is rescued by the depletion of 53BP1 16 .
Recently, a novel role for RNA in the DNA damage signaling and repair has emerged [17] [18] [19] [20] [21] [22] [23] [24] [25] . In particular, we have reported that RNA polymerase II (RNA pol II) is recruited to DSBs, where it synthesizes damage-induced long non-coding RNAs (dilncRNAs) 17, 18 . DilncRNAs are processed to generate DNA damage response RNAs (DDRNAs), which promote DDR signaling 17, 18, 21, 25 .
Similar RNA molecules, named diRNAs, contribute to DSB repair by HR [22] [23] [24] .
It has recently been demonstrated in Schizosaccharomyces pombe that DNA:RNA hybrids form at DSBs in a tightly regulated fashion 26 . Recent reports also suggest that DNA:RNA hybrids may form at DSBs in mammalian cells 27, 28 . However, DNA:RNA hybrid formation at DSBs in mammalian cells has not been investigated in depth yet, nor has any characterization of the molecular mechanisms leading to their formation or metabolism at DSBs been reported. Control of DNA:RNA hybrid levels can be achieved either by avoiding their formation during transcription, or by unwinding or degradation of already-formed hybrids by helicases and RNase H enzymes, respectively. In eukaryotic cells, DNA:RNA hybrids are degraded by RNase H1 and RNase H2, the latter accounting for the majority of RNase H activity in mammalian nuclei. RNase H2 is a heterotrimeric complex composed of a conserved catalytic subunit, called RNase H2A, and auxiliary subunits RNase H2B and RNase H2C, which mediate the interaction with additional proteins 29 . RNase H2, in addition to its role in removing misincorporated ribonucleotides from genomic DNA 30, 31 , is also responsible for the resolution of DNA:RNA hybrids generated by RNA pol II during transcription 32, 33 . Very recently, RNase H2 was also shown to regulate DNA:RNA hybrid levels at telomeres 34 . Furthermore, a physiologic role for human RNase H2 was uncovered through the discovery that mutations in any of its subunits cause the Aicardi-Goutieres syndrome (AGS), a neuroinflammatory disease associated with the chronic activation of the immune system in response to an excessive accumulation of aberrant forms of nucleic acids 35 .
Strong links between HR proteins, RNA, and DNA:RNA hybrids have already been demonstrated and continue to emerge: BRCA1 interacts with several transcription and RNA-processing factors including RNA pol II 36,37 , recognizes and promotes the processing of miRNA precursors 38 , and mediates the recruitment of the DNA/RNA helicase SENATAXIN to gene terminators to avoid genome instability induced by DNA:RNA hybrid accumulation 39 . Depletion of BRCA1 or BRCA2
results in the accumulation of DNA:RNA hybrids globally 40, 41 and specifically at promoter proximal sites of actively transcribed genes 42, 43 .
In addition, proteins involved in the fanconi anemia (FA) repair pathway are recruited to DNA damage sites via DNA:RNA hybrids to suppress hybrid-associated genomic instability 44, 45 .
Altogether these results suggest a yet undefined but emerging intimate relationship between DNA:RNA hybrids and the HR repair pathway.
Herein, we explore the links between RNA, DNA:RNA hybrid formation and metabolism, and HR.
We show that dilncRNAs generated at DSBs contribute to the recruitment of the HR proteins BRCA1/BRCA2/RAD51 to DSBs. Specifically, in the S/G2 cell-cycle phase dilncRNAs pair to the resected DNA ends to form DNA:RNA hybrids which are directly recognized by BRCA1 and in this way they facilitate its recruitment to DSBs. Moreover, we demonstrate that RNase H2 is recruited to DSBs in the S/G2 cell-cycle phase and is in a complex with the HR proteins BRCA1/BRCA2/PALB2/RAD51, and that BRCA2 impacts on DNA:RNA hybrid levels by mediating RNase H2 recruitment to DSBs. Combined, our findings suggest a role for DNA:RNA hybrid formation and resolution in the HR process and provide a mechanistic model for the emerging interplay between DNA:RNA hybrids and HR proteins.
Results

DNA:RNA hybrids form at resected DNA ends in S/G2-phase cells
Recently, we reported that RNA pol II is recruited to DSBs where it transcribes dilncRNAs bidirectionally starting from exposed DNA ends 17 . In the same experimental setup where dilncRNAs were characterized, we investigated whether they could form DNA:RNA hybrids. We induced a site-specific DSB by transfecting HeLa cells with the I-PpoI nuclease, whose nuclear localization is induced by 4-hydroxytamoxifen (4-OHT). Upon I-PpoI-mediated DSB generation within the weakly transcribed DAB1 gene ( Supplementary Fig. 1a) , we monitored the formation of DNA:RNA hybrids by DNA:RNA hybrids immunoprecipitation (DRIP): briefly, non-crosslinked DNA:RNA hybrids were immunopurified with the specific S9.6 monoclonal antibody and analysed by qPCR. We observed that DSB generation induces the formation of DNA:RNA hybrids peaking at ~1.5kb and up to 3 Kb from both sides of the DSB (Fig. 1a,b) , consistently with the already reported dilncRNAs generation upon cut 17 . Importantly, when cut samples were treated with RNase H, levels of DNA:RNA hybrids strongly decreased, demonstrating the specificity of the DRIP signal (Fig. 1b) .
The accumulation of DNA:RNA hybrids at both sides of the DSB resembled the RNA Pol IImediated de novo bidirectional transcription of dilncRNAs from the DSB 17 , suggesting that dilncRNAs, rather than pre-existing RNA, such as a mRNA, were generating the observed hybrids (Fig. 1a) . To further confirm this observation, we monitored DNA:RNA hybrid accumulation at a DSB within a non-genic I-PpoI target site in HeLa cells ( Supplementary Fig. 1a ). Indeed, DSB induction by I-PpoI led to DNA:RNA hybrid accumulation also at this site (Fig. 1c) , thus supporting the notion that DSBs induce the synthesis of de novo transcripts that form DNA:RNA hybrids at DSBs. In order to extend this observation to another non-genic region generated in a different cellular system in which DSBs are induced by a different nuclease, we used DSB inducible via AsiSI (DIvA) U2OS cells ( Supplementary Fig. 1a ), where nuclear localization of the AsiSI restriction enzyme to the nucleus is induced by 4-OHT to generate DSBs at distinct locations 46 ( Supplementary Fig. 1b,c) . By DRIP-qPCR analyses, we observed DNA:RNA hybrids accumulation at the DSB in a non-genic AsiSI cleavage site (Fig. 1d) . Consistently, strand-specific reverse transcription followed by qPCR confirmed dilncRNAs accumulation upon damage at this non-genic AsiSI cleavage site ( Supplementary Fig. 1d ).
Since dilncRNAs production is dependent on RNA pol II 17, 18 , we tested whether RNA pol II inhibition with 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) affected DNA:RNA hybrid generation. DRIP-qPCR at the I-PpoI cleavage site within the DAB1 gene in HeLa cells treated with DRB, or with vehicle only, prior to DSB induction, revealed that DNA:RNA hybrid accumulation at the damaged site was dependent on RNA pol II ( Supplementary Fig. 1e ).
Having demonstrated that DNA:RNA hybrids accumulate at I-PpoI-and AsiSI-induced DSBs regardless of the genomic location and that their formation requires RNA pol II activity, we reasoned that, during the S/G2 cell-cycle phase, DNA-end resection and consequent single-stranded DNA generation could provide a suitable DNA substrate for dilncRNA pairing to their resected template DNA and allow hybrids formation (Fig. 1a) . We therefore tested whether DNA:RNA hybrid formation is modulated during the cell-cycle by using HeLa-FUCCI cells, which express the fluorescent ubiquitination-based cell-cycle indicators (FUCCI) 47 . Following I-PpoI expression, we sorted cells into G1-and S/G2-phase populations and we monitored by DRIP-qPCR DNA:RNA hybrid accumulation. Importantly, DNA:RNA hybrids accumulation was analysed at 1.5 Kb on the right from the I-PpoI-induced DSB within the DAB1 gene, where the resected DNA end could pair only with the newly-synthesised dilncRNA and not with a potentially pre-existing mRNA (Fig. 1a) .
We observed that, upon DSB induction, DNA:RNA hybrids accumulate preferentially in the S/G2-phase of the cell-cycle (Fig. 2a) .
We next aimed to extend our observations to DSBs formed throughout the genome by an independent approach. To that end, we utilized super-resolution fluorescence microscopy (STORM) and analysed U2OS cells synchronized in G1-or S-phase and treated with the radiomimetic drug neocarzinostatin (NCS). We determined the extent of co-localization between the DDR marker γH2AX and DNA:RNA hybrids detected by S9.6 antibody by quantifying the overlaps of their signals in each cell relative to the calculated number of overlaps present due to random distribution 48, 49 . Importantly, the wider distribution of γH2AX compared to DNA:RNA hybrids was also accounted for in our analysis by this approach. We observed an increased rate of co-localization between γH2AX and DNA:RNA hybrids in S-compared to G1-phase cells (Fig. 2b,c) .
Given the preferential DNA:RNA hybrid accumulation at DSBs in the S/G2 cell-cycle phase, we tested the contribution of DNA-end resection to their formation. To this aim, we knocked-down CtIP and we monitored DNA:RNA hybrid accumulation by DRIP-qPCR at 1.5 Kb on the right from the I-PpoI cleavage site within DAB1 gene, as above, at different time-points after cut induction.
We observed that inhibiting resection by knocking-down CtIP prevented DNA:RNA hybrid formation ( Fig. 2d and Supplementary Fig. 2a ). Impaired DNA:RNA hybrids formation was also observed when extensive DNA end resection was inhibited by EXO1 knock-down ( Fig. 2e and Supplementary Fig. 2b ). As a control, neither CtIP nor EXO1 knock-down altered cell-cycle phases distribution (Fig. 2f) .
Collectively, these results show that DNA:RNA hybrids form at DSBs, as independently demonstrated site-specifically by DRIP analyses at genic and non-genic loci and genome-wide by super-resolution imaging, and that their accumulation requires RNA pol II activity. Moreover, DNA:RNA hybrids formation occurs preferentially during the S/G2 cell-cycle phases and it is favored by DNA-end resection controlled by CtIP and EXO1.
dilncRNAs contribute to HR proteins recruitment to DSBs and HR-mediated repair
We next studied the impact of transcriptional inhibition on DNA-end resection and on the focal accumulation of HR proteins which are specifically recruited to DSBs in the S/G2 cell-cycle phase.
In order to test this, we acutely inhibited RNA pol II activity with α-amanitin or DRB and we simultaneously irradiated (5Gy) HeLa cells -effective RNA pol II inhibition was confirmed by monitoring by RT-qPCR c-FOS mRNA level, a specific RNA pol II transcript with a short half-life ( Supplementary Fig. 3a,b) . DNA-end resection was measured by immunofluorescence analyses of exposed ssDNA through native staining of incorporated BrdU, total RPA and its phosphorylated form (RPA2 pS4/8) -focal signals were quantified in S/G2 cells, as monitored by the S/G2-phase marker cyclin A. Consistently, all three markers revealed proficient DNA-end resection upon RNA pol II inhibition (Fig. 3a,b and Supplementary Fig. 3c ). Next, we monitored the impact of transcriptional inhibition by α-amanitin or DRB on the focal accumulation of HR proteins. We observed that both treatments significantly impaired the formation of the foci of BRCA1, BRCA2, and RAD51 (Fig. 3c,d and Supplementary Fig. 3d ), this is despite unaltered protein levels ( Supplementary Fig. 3e ,f).
We next sought to test a direct role of dilncRNAs in HR. For this, we employed the DR-GFP reporter cell system 50 in which HR between a mutated integrated GFP construct, containing the ISceI recognition site, and a truncated GFP generates a functional GFP open reading frame ( Supplementary Fig. 3g ). Following I-SceI induction, HR can be monitored by either the evaluation of GFP expression by FACS analysis in individual cells or, more directly but in bulk, by PCR amplification of the recombined genomic DNA sequence. We impaired dilncRNAs functions by complementary Antisense Oligonucleotides (ASOs) ( Supplementary Fig. 3g ) -ASOs are modified oligonucleotides widely used to inhibit the function of their target RNAs 51 and have been previously used by our group to target dilncRNAs and inhibit DDR 17, 18 . We transfected different sets of ASOs complementary to the predicted dilncRNAs generated at the I-SceI locus and simultaneously induced I-SceI for 72 hours. Both FACS analysis of GFP expression (Fig. 3e ) and PCR to detect the recombined genomic locus (Fig. 3f ) demonstrated that ASOs matching dilncRNAs reduced HR efficiency, while an ASO matching an unrelated sequence (CTRL) had no impact on HR (Fig. 3e,f) . Importantly, the same effective ASOs inactivated by annealing with complementary sequences (Inactive) did not inhibit HR, and all the ASOs left cell-cycle unaltered ( Supplementary Fig. 3h ). In this same cell system, genomic PCR can also be used to study SSA, a RAD52-dependent but RAD51-independent mechanism that shares with HR the initial DNA-end resection step. We observed that ASOs did not inhibit SSA (Fig. 3g) , further indicating that dilncRNAs inactivation impacts the HR process downstream of DNA-end resection.
These results show that dilncRNAs, while not affecting DNA-end resection, contribute to the recruitment of HR proteins to the site of damage and, by doing so, they promote HR.
DNA:RNA hybrids are directly recognized by BRCA1 in vitro and promote its recruitment to
DSBs in living cells
Based on our observations that dilncRNAs form DNA:RNA hybrids in S/G2-phase cells and control the recruitment of HR proteins to sites of DNA damage, we sought to test the involvement of DNA:RNA hybrids in the focal accumulation of HR proteins at DSBs. By performing superresolution imaging and analyzing the extent of co-localization between BRCA1 and DNA:RNA hybrids in NCS-treated U2OS cells synchronized in S-phase, we observed that the few detectable DNA:RNA hybrids often co-localize with BRCA1 in S-phase cells upon damage (Fig. 4a,b ).
To test whether BRCA1 can directly recognize DNA:RNA hybrids, we used purified recombinant human BRCA1 or the constitutive BRCA1-BARD1 heterodimer in an electrophoretic mobility shift assay (EMSA) with either DNA duplexes or DNA:RNA hybrids. Radioactively-labelled probes were incubated with the recombinant proteins and separated by electrophoresis on a native polyacrylamide gel. Both BRCA1 alone and BRCA1-BARD1 bound the DNA:RNA hybrid, with an affinity comparable or higher than that for dsDNA ( Fig. 4c,d ).
Having observed that BRCA1 can bind DNA:RNA hybrids, we tested whether modulation of DNA:RNA hybrids level at DSBs in living cells impacted its recruitment. To this purpose, we monitored BRCA1 foci formation at DSBs in irradiated (2Gy) U2OS cells expressing RNase H1 fused to GFP, or GFP alone as a control. We observed that RNase H1 overexpression impaired ionizing radiation-induced BRCA1 foci formation ( We observed that RNase H treatment reduced the amount of BRCA1 foci ( Fig. 4g,h ), while not impacting neither on the number of γ-H2AX foci ( Supplementary Fig. 4a ), nor on DNA-end resection, as determined by RPA foci ( Supplementary Fig. 4b ).
These results show that DNA:RNA hybrids can be directly recognized by BRCA1 in vitro, and in living cells they contribute to BRCA1 recruitment to DSBs.
RNase H2 is recruited to DSBs during the S/G2 cell-cycle phase
Although DNA:RNA hybrids promote the early steps of HR by favoring BRCA1 loading at DSB, it is known that their excessive accumulation may be detrimental for HR 28 . This suggests that their levels at DSBs need to be tightly controlled. Since RNase H2 is the major source of RNase H activity in mammalian nuclei 29 , we tested its recruitment to DSB by performing chromatin immunoprecipitation (ChIP) and assaying for RNase H2A enrichment at the I-SceI cut site in the DR-GFP system. We observed an enrichment of RNase H2A around the I-SceI cleavage site in cut DR-GFP cells relative to uncut cells ( Fig. 5a ), to an extent similar to that observed for BRCA1 ( Fig.   5b ), while no enrichment was detected in an unrelated region in cut versus uncut (Fig. 5a ,b). To further validate this result with a different technique and at multiple genomic sites, we performed immunofluorescence microscopy to detect RNase H2 subunits in irradiated or not irradiated cells.
However, such stainings showed a diffuse signal that failed to highlight discrete foci under all the conditions tested (data not shown). To increase the sensitivity and specificity of the signal, we performed proximity ligation assay (PLA) between RNase H2A and γH2AX in not irradiated or irradiated (2Gy) U2OS cells fixed 1 or 6 hours after irradiation. We observed an increase in PLA signals between RNase H2A and γH2AX in irradiated cells ( Fig. 5c and Supplementary Fig. 5a ), thus suggesting that the two proteins become in close proximity upon irradiation. As a negative control, no signal was detected when only one of the two primary antibodies was used ( Supplementary Fig. 5b ,c) and, as a reference, a comparable PLA signal was observed between γH2AX and the HR marker RAD51 ( Supplementary Fig. 5d ). Since damage-induced DNA:RNA hybrids preferentially accumulate in the S/G2 cell-cycle phase, we monitored RNase H2 recruitment to DSBs in irradiated (2Gy) and not irradiated HeLa-FUCCI cells. In this setup, we observed an increase in PLA signals between γH2AX and RNase H2A in S/G2-phase irradiated cells compared to G1 or to S/G2 not irradiated cells ( In order to further extend our observations with an independent approach, we performed superresolution imaging analysis of γH2AX and RNase H2A co-localization in U2OS cells treated with NCS and we measured the extent of co-localization relative to random events. In agreement with PLA results, we observed that RNase H2 co-localized with γH2AX in NCS-treated S-phase cells ( Fig. 5f,g ).
Overall, these results consistently indicate that RNase H2 is recruited to DSBs, both induced at a specific locus and genome-wide, preferentially during the S/G2-phase of the cell-cycle.
BRCA2 is in a complex with RNase H2 and controls DNA:RNA hybrid levels at DSBs
Published reports suggest BRCA2 as a possible regulator of DNA:RNA hybrids cellular levels 40 .
To test whether DNA:RNA hybrid levels at DSBs could be controlled by BRCA2 through RNase H2 recruitment, we performed PLA between γH2AX and RNase H2A in S/G2-phase irradiated (2Gy) HeLa-FUCCI cells knocked-down for BRCA2. We observed that RNase H2A recruitment to DSBs was reduced in cells knocked-down for BRCA2 (Fig. 6a,b and Supplementary Fig. 6a ), despite no significant differences in γH2AX foci numbers ( Supplementary Fig. 6b ). The observed requirement of BRCA2 for RNase H2 recruitment to DSBs prompted us to test whether the two proteins could form a complex. We thus performed immunoprecipitation experiments from cell lysates of irradiated and not irradiated HEK293T cells prepared in the presence of benzonase to degrade all contaminating nucleic acids. We observed that RNase H2A co-immunoprecipitates with BRCA2 and other proteins of the HR machinery, including BRCA1, PALB2, and RAD51, independently of DNA damage induction (Fig. 6c ). This interaction was specific within this complex since no interactions with proteins known to be part of other BRCA1 complexes, such as CtIP and RAP80, were observed ( Supplementary Fig. 6c ).
In order to test whether the impaired RNase H2 localization to DSBs upon BRCA2 inactivation resulted in increased DNA:RNA hybrid levels at DSBs, we performed DRIP-qPCR at the I-PpoI site within the DAB1 gene in S/G2-phase-sorted HeLa-FUCCI cells knocked-down for BRCA2 -sorting of the S/G2-phase cells population was necessary since BRCA2 inactivation affects the cellcycle (data not shown). DRIP-qPCR analysis revealed a significantly increased accumulation of DNA:RNA hybrids at the DSB in the absence of BRCA2 ( Fig. 6d and Supplementary Fig. 6a ),
indicating that BRCA2, likely via the recruitment of RNase H2, regulates DNA:RNA hybrid levels at DSBs. Interestingly, RAD51 knock-down in the same experimental conditions did not significantly alter DNA:RNA hybrid levels at the tested DSB ( Supplementary Fig. 6d ,e).
Altogether these results show that RNase H2A is in a specific complex with HR proteins, including BRCA1, PALB2, BRCA2, and RAD51, and that BRCA2 controls DNA:RNA hybrid levels at DSBs by mediating RNase H2 recruitment to DSBs.
Discussion
We have recently demonstrated that in mammalian cells RNA pol II is recruited to exposed DNA ends upon breakage, where it bidirectionally transcribes RNA species named dilncRNAs 17 . In the present study, we show that DNA:RNA hybrids form at DSBs most likely upon hybridization of dilncRNAs generated at DSBs with the resected ends of their template DNA in the S/G2-phase of the cell-cycle. In this way, dilncRNAs contribute to the recruitment of key HR proteins to DSBs 53 . In line with this and with data generated in S. pombe 26 , we show that DNA:RNA hybrids form in the S/G2 cell-cycle phase upon exposure of resected DNA ends to the complementary RNAs. Importantly, here we show for the first time that DNA:RNA hybrids form at DSBs in both genic and non-genic regions, thus indicating that the RNA component of these hybrids is unlikely to be be a pre-existing transcript, but rather could be a newly transcribed dilncRNA. Further supporting this observation, we also demonstrate that the presence of resected DNA ends is required for DNA:RNA hybrids accumulation at DSBs. This indicates that DNA:RNA hybrids formation, even in genic regions, cannot only be the result of pairing of the pre-existing mRNA to the template DNA, since it would occur only on one side of the DSB: the one with exposed ssDNA matching the pre-existing transcript (see Fig. 1a ). Differently, the observed DNA:RNA hybrids accumulation at both sides of DSBs is only compatible with newly bidirectionally transcribed dilncRNAs pairing with their template resected DNA ends. Interestingly, the reported need for pre-existing transcription to promote RNA-mediated repair in Saccharomyces cerevisiae 54 is consistent with the reported lack of recruitment of RNA polymerase II to DSB and lack of transcriptional induction in this species 55 .
Our work also shows that RNA pol II transcription contributes to the focal accumulation of the HR proteins BRCA1, BRCA2, and RAD51 at DSBs, while it does not seem necessary for DNA-end resection. Accordingly, site-specific inactivation of dilncRNAs by complementary ASOs inhibits repair by HR, but does not affect SSA, which requires extensive DNA ends resection but differs from HR in the subsequent steps. The observation that transcriptional inhibition does not reduce DNA-end resection while impairing BRCA1 foci formation was unexpected. However, it can be explained by considering the concomitant reduced 53BP1 foci formation upon transcriptional inhibition or ASO treatment 17 . Indeed, since BRCA1 is required to oppose the inhibitory effect of 53BP1 on DNA-end resection, in the absence of 53BP1, as upon RNA pol II inhibition or ASO treatment, BRCA1 may become dispensable for this process 15 . This could also explain the observed stronger impact of transcriptional inhibition on BRCA1 recruitment to DSBs compared to BRCA2 and RAD51. Notably, the moderate increase of DNA-end resection observed upon transcriptional inhibition may be caused either by a higher efficiency of the resection process, or, more intriguingly and consistently with our model, by an increased availability of single-stranded 29 , interacts with the HR machinery components, including BRCA1, BRCA2, PALB2, and RAD51, and that BRCA2 contributes to its recruitment to DSBs specifically during the S/G2 cell-cycle phase. Indeed, BRCA2 inactivation boosts DNA:RNA hybrid levels at DSBs. This observation is not only consistent, but it could actually mechanistically explain the increased DNA:RNA hybrid levels observed in BRCA2-depleted cells by others 40 . In light of our conclusions, it will be interesting to study the DNA:RNA hybrid levels at DSBs in conditions in which RNase H2 is mutated, as in AGS patients.
In summary, we propose a model (Fig. 6e) 
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RNase H treatment
U2OS cells were plated on coverslips and irradiated (2Gy) and RNase H treatment was performed according to a published protocol 53 . Next, coverslips were washed twice in PBS 1X and fixed and stained as described in the "immunofluorescence" section.
RNA extraction
Total RNA from cultured cells was extracted with Maxwell® RSC simplyRNA Tissue Kit with the Maxwell® RSC Instrument (Promega), according to manufacturer instructions. RPPO was used as normalizer.
For dilncRNAs detection, chromatin-bound RNA was retro-transcribed using the Superscript IV First Strand cDNA synthesis kit (Invitrogen) with strand-specific primers. Expression of dilncRNAs was determined by RT-qPCR using EvaGreen Supermix (Bio-Rad).
Immunofluorescence and imaging analysis
Cells were fixed in 4% paraformaldehyde (PFA) for 10 min at RT. For BRCA2 staining cells were fixed in ice-cold methanol for 10 min. Immunofluorescence was performed as described 
DR-GFP reporter assay
I-SceI expression was induced by adding 5 µg/ml doxycycline and 72 h later the HR efficiency was determined by quantifying GFP-positive cells (product of successful HR) by flow cytometry, as described in the section "Fluorescence-activated cell sorting (FACS)". A PCR method was also used to monitor HR and SSA. DNA was extracted with the DNeasy Blood & Tisue Kit (Qiagen) and PCR was performed with the GoTaq® DNA Polymerase (Promega). HR was monitored by measuring the intensity of the amplicon generated by the primers P1 and P2 60, 61 . SSA was monitored by measuring the intensity of the amplicon generated by amplification with primer F and R2 60, 61 . Both the measurements were normalized on the actin amplicon. Sequences of the primers are listed in table 3. diluted in 5% milk in TBS-T. After 3 more washes with TBS-T, HRP activity was detected using a Chemidoc imaging system (Bio-Rad) machine after adding the substrate for the enhanced chemiluminescent reaction ECL (GE Healthcare).
Immunoblotting
Immunoprecipitation
HEK293T cells were collected and lysed in TEB150 lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 2 mM MgCl 2 , 5 mM EGTA pH 8, 1 mM DTT, 0.5% Triton X-100, 10%
glycerol, protease inhibitor cocktail set III (Calbiochem) and Benzonase 1:1000 (Sigma) for 45 min at 4 o C. Usually, 1 mg of the protein lysate was used per each immunoprecipitation in a reaction volume of 500 µl. As input, 1% of the immnoprecipitation reaction was collected and denatured in the sample buffer (50 mM Tris-HCl pH 6.8; 2% SDS; 10% glycerol; 12.5 mM EDTA; 0.02 % bromophenol blue; 100 µM DTT) for 10 min at 95 o C. Unspecific binding of proteins to the beads was reduced by incubating samples with Protein G beads (50 µl) (Zymed Laboratories) for 1 hour at 4 o C (pre-clearing). Binding reactions were performed overnight at 4 °C and were followed by addition of protein G-Sepharose beads for 2 h. After 3-6 washes with lysis buffer, immunoprecipitated proteins were released by the addition of sample buffer and incubation at 95 o C for 10 min.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described previously 62 . Briefly cells were cross-linked and chromatin was sonicated with a Focused-Ultrasonicator Covaris to obtained fragments of ~500 bp. 50
µg of chromatin were used per sample. DNA was cleaned up by QIAquick PCR purification column (Qiagen) according to the manufacturer's instructions and Roche SYBR Green-based qPCR experiments were performed on a Roche LightCycler 480 machine (see table 3 for primers sequence).
DNA:RNA hybrids immunoprecipitation (DRIP)
DRIP was performed following a published protocol 40 . 
Fluorescence-activated cell sorting (FACS)
For GFP analysis, 10 6 cells were fixed in 1% formaldehyde for 20 min on ice. Next, cells
were washed in PBS with 1% BSA and fixed in 75% ethanol. Fixed cells were washed again in PBS with 1% BSA and stained with propidium iodide (PI) (Sigma-Aldrich, 50 µg/ml) in PBS supplemented with RNase A (Sigma-Aldrich, 250 µg/ml).
For cell cycle analysis, 10 6 cells were directly fixed in 75% ethanol, as described above.
Samples were acquired on an Attune NxT machine and analyzed with FlowJo_V10 software.
At least 10 4 events were analyzed per sample.
For sorting of HeLa-FUCCI cells, cells were collected in PBS with 2% FBS and the G1 and S/G2 population were sorted with a MofloAstrios (Beckman Coulter) in PBS supplemented with RNaseOUT (Thermo Fisher). Sorted samples were processed for DRIP as described in the section "DNA:RNA hybrids immunoprecipitation (DRIP)".
Cloning, expression and purification of recombinant proteins
Recombinant BRCA1 was expressed and purified as a complex in Sf9 cells by co-infection with baculoviruses prepared from individual pFastBac1 plasmids pFB-2xMBP-BRCA1-10xHis. Bacmids, primary and secondary baculoviruses were obtained using standard procedures according to manufacturer's instructions (Bac-to-Bac, Life Technologies). Sf9 cells were transfected using a Trans-IT insect reagent (Mirus Bio).
For the large-scale BRCA1 expression and purification, Sf9 cells were seeded at 0.5x106 per ml and infected 16 h later with recombinant baculoviruses expressing pFB-2xMBP-BRCA1- PMSF, 1 mM; imidazole, 20 mM). Prior to elution, the protein was washed once with the same NiNTA wash buffer listed above but with only 150 mM NaCl. Pooled fractions were stored at -80°C.
Electrophoretic mobility shift assay
The 50 bp-long dsDNA substrate was prepared by annealing oligonucleotides X12-3
(5' GACGTCATAGACGATTACATTGCTAGGACATGCTGTCTAGAGACTATCGC3') and X12-4C
(5' GCGATAGTCTCTAGACAGCATGTCCTAGCAATGTAATCGTCTATGACGTC 3')
